THE CLINICAL UTILITY OF 18F- FLUCICLOVINE PET/MRI IMAGING TWO YEARS FOLLOWING FOCAL CRYO-ABLATION (FCA) OF PROSTATE CANCER

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Prostate Cancer
  • Age: Between 18 - 100 Years
  • Gender: Male
  • Other Inclusion Criteria:
    1) FCA at NYU Langone Health performed at least two years prior to study enrollment by Drs. Lepor or Wysock. 2) No prostate cancer specific treatment following FCA 3)Consented to undergo reflex MRI and prostate biopsy two years following FCA.

You may not be eligible for this study if the following are true:

  • 1) Any contraindication to prostate biopsy. 2) Prior allergic reaction to Axumin. 3) Patient refuses MRI and prostate biopsy two years following FCA.


If you are registered as a volunteer, please login to the dashboard to send referrals.